 "Bayer CropScience falls 8% on disappointing Q2 results")
Shares of agrochemicals firm Bayer CropScience dipped 8% to Rs 3,865 on the BSE after it reported 25% drop in its net profit at Rs 1,427 million in September quarter, due to lower income. The company had profit of Rs 1,906 million in the corresponding quarter of previous fiscal.
In Q2 of FY2018-19, the company registered revenue from operations of Rs 11,041 million as compared to Rs 12,320 million in the corresponding period of FY2017-18.
“Sales were affected due to an erratic season marked by uneven rainfall and hailstorms that damaged standing crops in several parts of the country,” said Richard van der Merwe, vice chairman & managing director, Bayer CropScience.
Based on opportunities in the fruits & vegetables segment and in rice, the company said it expect a good performance in the third quarter and for the rest of the year.
In Q2 of FY2018-19, the company registered revenue from operations of Rs 11,041 million as compared to Rs 12,320 million in the corresponding period of FY2017-18.
“Sales were affected due to an erratic season marked by uneven rainfall and hailstorms that damaged standing crops in several parts of the country,” said Richard van der Merwe, vice chairman & managing director, Bayer CropScience.
Based on opportunities in the fruits & vegetables segment and in rice, the company said it expect a good performance in the third quarter and for the rest of the year.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%